The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma

The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma

The BNT162b2 COVID-19 vaccine is composed of lipid-nanoparticles (LNP) containing the mRNA that encodes for SARS-CoV-2 spike glycoprotein. Bronchospasm has been reported as an early reaction after COVID-19 mRNA vaccines in asthmatic patients. The aim of this study was to investigate the acute impact...

Full description

Bibliographic Details
Main Authors: Luigino Calzetta, Alfredo Chetta, Marina Aiello, Annalisa Frizzelli, Josuel Ora, Enrico Melis, Francesco Facciolo, Lorenzo Ippoliti, Andrea Magrini, Paola Rogliani
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Vaccines
Subjects:
airway hyperresponsiveness
asthma
BNT162b2
bronchospasm
comirnaty
COVID-19
Online Access:https://www.mdpi.com/2076-393X/11/2/282

Internet

https://www.mdpi.com/2076-393X/11/2/282

Similar Items